Re: RVX- Exempt Distribution. I believe this is your first post on the RVX Board so welcome. The invention comprises methods for treating and/or preventing cardiovascular, cholesterol, and lipid related disorders, including atherosclerosis, through co-administration of therapeutically effective amounts of RVX-208 or a pharmaceutically acceptable salt thereof and rosuvastatin or a pharmaceutically acceptable salt thereof. Where have I said "I believe both rvx & zen will be fine" this year? "just give me your understanding of what's going on without the nonsense please. message: rvx announces dosing of first two patients in expanded renal and orphan programs 17. profile Stock Quotes Press Releases Management. Hepalink IPO Document and what it says about. He's not wanting for money. I don't think I ever saw them break down the MACE numbers by type of statin. I've copied some of the highlights below. ) narmac, management has been chasing its tail since we learned in 2019 that BOM did not meet its endpoint. Back To Forum List ViewDid you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc. . 10BagR - The challenge with reverse splits versus forward splits is that reverses are usually done in distress situations and in many cases the share price decreases after the split. Getting data out of China could be an issue but if revenue resulted, it would help to move trials around the world along. If it's not a lot of cash to put elsewhere, it's also not a lot of cash if left in. . WT's are due this June and some of those original warrants have been exercised. 72 guess in for the contest. 50 Expires 2027-03-29. Message: Re: Hepalink IPO Document and what it says about RVX Reply New Message. -2. And there you have it KK2. Its principal asset is the Las Cristinas property in Bolivar State which is currently under development. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and. . We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY! Hub Navigation Hub Homemessage: re: rvx announces type c meeting with fda for coral, a phase 3 high-risk covid-19 outpatient studyOn November 2nd the Globe and Mail had a special section on diabetes. posted on Aug 13, 2023 04:18PM. A's are due in 2023. posted on Apr 01, 2022 11:23AM. . It's a huge if but if orphan status is received for nut midline that could be almost in the near future. . We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY! Hub Navigation Hub HomeMessage: Re: A few thoughts on Soliris(Eculizumab) vs. Discussion Parent. Rocketman2, I have tried researching how CVR deals work in terms of actual payments made to shareholders and I can't say that I really found what I was looking for so maybe someone on this board can either further clarify my comments and/or correct me if I am wong etc. Wow, a full warrant only 2 cents above subscription/market, and for FIVE years!!" "What happened to "Those selling shares on the market for $0. Hope springs eternal? At this point, my. Why is RVX being passed over if favor of even some smaller biotech startups with arguably less potential?? In light of ABL’s track record to date, why is even government funding so hard to obtain?? Why is this stock trading at 0. 2 Recommendationsmessage: rvx announces type c meeting with fda for coral, a phase 3 high-risk covid-19 outpatient study Reply New Message Prev Message Back To Forum Threaded View Next MessageMessage: Re: Hepalink IPO Document and what it says about RVX Reply New Message. A warrants = 3 mil + and the 2nd one the RVX. 08 cents? It has reputable people on research boards. A warrants = 3 mil + and the 2nd one the RVX. Unveiling Silvercorp's golden potential at the Ying Mining District. RVX Change of Auditors Jan 23, 2023 RESVERLOGIX CORP. We learn as we go. Even having bets where the share price will end up once we get the results on BOM. Do you think they were?" Yes, I think the results are positive with some caveats. Buckeyes, I got a kick out of your statement "Apples & Oranges compared with RVX, we were only a $10,000,000 revenues company,". For example, perhaps the decision to not do the futility analysis in BOM and the previous trial were the result of insufficient funds, hence losing 4 to 5 years in apabetalone’s march to being an approved drug. but has Seeking Alpha link to finished notes)Message: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020Message: Re: A clinical future for RVX-2135 or just a pre-clinical toolInteresting article Nextblockbuster. 002. AGORACOM Small Cap Marketing - 700M Page Views / 65M Visits / $0 Cash / 100% Compliance | 821 followers on LinkedIn. However, the golf season in the middle eastern countries is 52 weeks of the year, so I'm sure our diligent team of biotech financial geniuses is out there on the course trying to cut a deal. I have also heard that it has good traction with Key Opinion Leaders in Europe. We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY! Hub Navigation Hub HomeMessage: A few thoughts on Soliris(Eculizumab) vs. During this transaction, the name of RVX Therapeutics was. )Further to the idea of of how many 'A' are in circulation. Some other rumor or development leaking from the inside, such as pending funding for RVX? 4. , a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Experimental and clinical - 1 [SP071] APABETALONE (RVX-208), A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, DECREASES ABUNDANCE AND ACTIVITY OF COMPLEMENT PROTEINS IN VITRO, IN MICE AND IN CLINICAL STUDIES Norman C. RVCA x Birdwell collection lands on the Gold Coast. . It doesn’t matter much but this is how the transaction from RVX spinout to ZCC happened. . Zenith Epigenetics Ltd is a wholly owned subsidiary of Zenith Capital Corp. RVX-208 for Compliment-related disease. RVX Idea Mar 29 2023 Here’s a fun thought for Hump Day. 48 = $2,269,052. Look at some historical data and you will. New emphasis on combining multiple drugs with proven cardiovascular benefits mirrors Resverlogix. Rank: President Points: 3187 Votes: 23 Score: 3. It is the first time I have seen a first post get 9 Recommendations (so far) and 2, 5 Star Ratings. 260. Thanks for posting. Back To Forum List ViewWelcome to the Crystallex HUB on AGORACOM Crystallex International Corporation is a Canadian-based gold company with a successful record of developing and operating gold mines in Venezuela and elsewhere in South America Hub Navigation Hub Home. 60 warrants as a hope and prayer. RVX also. This is the Resverlogix patent for co-treatment with RVX-208 and rosuvastatin that Resverlogix was referring to in their September 2013 news release. Results "promising" albeit. Buckeyes, to your comment re China the following was just published in Nature. " I believe there are some very ticked off shareholders,. Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc. 00 CAN. The continued supportive and promising. . . ZCC would retain an 8% royalty on ZEN-3694 + the RVX royalty preferred shares. . Now we start over with a much longer trial with nothing to help the. message: rvx announces dosing of first two patients in expanded renal and orphan programsResverlogix Corp. 1 Colour. Let's say, for example, Zenith either hits it big with their ongoing studies and commercializes, or sells. Back To Forum List ViewMessage: According to the TMX website there are only 5 million RVX. The interview highlights key achievements, including a staggering 723% growth in Programmatic Ad Tech Revenue. 10% least volatile stocks in CA Market. Log in to use the IP Check tool [?] Regarding a "presentation", I don't think there was any presentation on BTV, the tweet RVX sent out only said catch a sneak preview of the "CEO Clip" and that it would be run on BNN on Oct 9 & 10. Why should they? They basically break even. Calgary, Alberta--(Newsfile Corp. What does the Jardiance/EMPA-REG Outcome result mean for RVX-208? Not much. WT. Poster Session: Renal pathology. )Message: Re: Would a functional cure for T1D affect RVX and T2D?The big question I have is what should RVX’s valuation look like with a successful Phase 2 for Covid and successful Emergency Use Authorization? To attempt to bookend this question, I looked at Moderna’s 2021 quarterly earnings and the EPS multiple they have been trading at. Message: Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020Message: Re: Hepalink IPO Document and what it says about RVX Reply New Message. 6. Re: Some history. Up to Aug 31st the number of shares short RVX as reported by Stockwatch is 602,792 which is drop of 54,305 from the Aug 15th number. profile Stock Quotes Press Releases Management. ZEL is a wholly owned subsiduary of ZCC so anything ZEL owns is owned by ZCC. You flushed out a valuable bit of information from RVX regarding the upcoming AGM and pre AGM expectations. This recently published study conducted at the Baker IDI Heart and Diabetes Institute (Melbourne, Australia) was relatively small (20 patients) and patients were only. )I've wondered if Dr Wong was offered a seat on the RVX BOD to replace Norma Biln instead of moving to a 5 person board, which gives Hepa and ORI 40% of the seats? And, the other big player, Eastern has no representation on the BOD and they abstained from voting in June 2022. Message: Re: What else can RVX treat that we don’t know about yet? Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc. Amazing that Hepa does not seem to be doing their. RVX abstract from the IDF 2015 Word Diabetes Congress in Vancouver Nov 30 to Dec 4 Epigenetic actions of RVX-208 lower major adverse cardiovascular events, MACE in patients with diabetes. As soon as I read this it seemed very familiar and reminded me of some posts a few years back when posters were trying to figure out Don's education level. The interview highlights key achievements, including a staggering 723% growth in Programmatic Ad Tech Revenue. Oct 13, 2017 - RESVERLOGIX ANNOUNCES $87 MILLION PRIVATE PLACEMENT WITH SHENZHEN HEPALINK. I bolded the parts that I find curious,. Absolutely –. RVX-297 also decreases the production of multiple cytokines in endotoxemic mice (Jahagirdar et al. I had questioned the fact that RVX recorded a liability at 10/31/15 for $30. We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY! Hub Navigation Hub HomeMessage: Zenith news can only help RVX and further validate Epigenetics science!If this is anything but bad news, this was a horrible news release. I don't think I ever saw them break down the MACE numbers by type of. Dec 12, 2017 - NATURE’S RECENT. EMPA-REG Outcome would have failed to achieve the 30% overall MACE reduction that RVX-208. Just a couple of small corrections. . Royalty on the sale of RVX-208 is 6% to 12% and Zenith Capital Corp could start receiving royalty revenue on sales of ZEN-3694 years before royalties from RVX-208 begin. )message: re: rvx announces type c meeting with fda for coral, a phase 3 high-risk covid-19 outpatient study. Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc. What gives? Why the apparent disinterest on behalf. General360 wrote "We recently heard about a particular type of MS, i'm wondering about our litlte miracle RVX-208 and it's impact on inflammation in general, MS and Rab32 in particular. retail shareholders To the very rich insider owners, That being said, I think that Norman Wong , DM have discovered a small molecule drug That may cure many diseases, phase 3 will be the tell sign, but of course there are no Guarantees, my comfort is in the post hoc. Phase 3 COVID-19 Clinical Trial – CORAL. but only if you want it! Reply New Message Prev Message Back To Forum Threaded View Next Message. WT. We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY! Hub Navigation Hub HomeComplete Resverlogix Corp. Dec 31 2022 Financial show a cash position of $40K Exempt Distribution of 2023-03-06 totalled $32K. They understandably now have much bigger fish to fry. Las Cristinas’ estimated 17. 7. 0. There would be no chance they'd be funded by the NIH, who are very careful. This is the Resverlogix patent for co-treatment with RVX-208 and rosuvastatin that Resverlogix was referring to in their September 2013 news release. As per this article, the biggest premium paid for a biotech since 2015 is 282% of the share price, and that's in a perfect storm. We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY! Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple. A grab sample from Target Area 1 returned assay values of 12. Keep in mind the Resverlogix's BETonMACE has a primary endpoint of 30% MACE reduction (combined endpoint of death, heart attack and stroke). Day traders and market. Welcome to the Crystallex HUB on AGORACOM. Feel free to correct. Message: RVX AHA Presentation 191116 - CORRECTED AGAIN (same as last correction in other message)Message: Re: Would a functional cure for T1D affect RVX and T2D?Hi tada. One month to go! On April 19th the payout of the debenture is due to Hepalink. $110. I hadn’t bothered reading it until a few days ago and there some very interesting information. Calgary, Alberta--(Newsfile Corp. . 20 BONUS POINTS FOR RVCA INSIDERS. Amazing that only $60,000,000 is needed to get BoM2 moving and it's been 4 years since the end of BoM. . I believe that RVX science has earned this trust in spite of underfunded, under powered trials that still have yielded incredibly promising results for CVD, CKD, vascular dimentia and many other indications that unfortunately are not being funded because management lacks the requisit financial skills. Re: Some history. fuzzyjr - What specific posts are you referring to, posted this year for me stating "exciting times ahead"', "defended this groups actions",. . The Phase 1 New Zealand Renal Trial with RVX-208 (aka apabetalone, RVX000222) is listed on the Australian New Zealand Clinical Trial Registry. . Conference runs May 21 to May 24. You never did own Royalty Preferred Shares in ZCC. Crystallex International Corporation is a Canadian-based gold company with a successful record of developing and operating gold mines in Venezuela and elsewhere in South America. . Koo (IMO) 4 Recommendations. Pretty cool actually. Re: RVX- Exempt Distribution. 60 g/t Pd + Pt from a. The viability of royalty sales to fund the trial. 45 can knock themselves out because I won't finance for. Go to that website above and scroll down a bit and you can get the pdf (or try clicking here ). . This appeared on Fox News today: "A new study from the National Institutes of Health found that one in 10 people are getting long COVID after suffering an omicron infection – a lower estimate than earlier on in the COVID-19 pandemic. S. That deal format looks eerily familiar, just change a few numbers. Without that I would not have been able to decipher my cryptic notes in as much detail as I have. Its principal asset is the Las Cristinas project in Bolivar State, which is currently under development. Google it. The impression I received from his email to you is that it is designed to precondition expectations (soften the blow) for the June. . Philadelphia, PA, Feb. Experimental and clinical - 1 [SP071] APABETALONE (RVX-208), A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, DECREASES ABUNDANCE AND ACTIVITY OF COMPLEMENT PROTEINS IN VITRO, IN MICE AND IN CLINICAL STUDIES . I keep thinking I'm done. It seems that RVX has more than 9 lives. posted on Oct 12, 2021 02:51PM. Resverlogix Cost $40MM +Message: Re: Hepalink IPO Document and what it says about RVX Reply New Message. Management has made another NR that begs more questions than it answers but I do find it absolutely incredible that it has taken over two years to start a "short inexpensive trial" and then come to the conclusion that it is the wrong trial. It is my belief that RVX will seek to do any ODP under the auspices of the EMA. 45 can knock themselves out because I won't finance. Corporate Profile: Crystallex International Corporation is headquartered in Toronto, Canada and has operations and exploration properties in Venezuela. 3%. Apabetalones' target of BD4 in pill form seems to offer a distinct advantage both in the science and cost. Message: Re: Zenith Epigenetics Corp (ZEC) held the shares issued to RVX shareholders in June 2013. One month to go! On April 19th the payout of the debenture is due to Hepalink. . Let's say, for example, Zenith either hits it big with their ongoing studies and commercializes, or sells. profile Stock Quotes Press Releases Management. 8% of RVX; I was under the impression that they were north of 40%. Log in to use the IP Check tool [?] "Warrant: $0. 8 MILLION LOAN. )message: re: rvx announces type c meeting with fda for coral, a phase 3 high-risk covid-19 outpatient study. 99. )RVX Thought Mar 19 2023 Here, just for fun, is some Monday morning quarterbacking on a Sunday. Message: Empowerment for the whining peasants, aka RVX retail. $ 59. It has Eversana doing something with it, presumably. . Personally I find it hard to believe that our big RVX investors are gonna take a deal as low as a $3. (RVX. There would be no chance they'd be funded by the NIH, who are very careful. We all felt that it was a sure thing. so farSan Fran I couldn't agree more, these are trying times for all RVX minority shareholders and I share your discomfort. Myovant Sciences, Inc. It is sort of saying that HL is capped at 50% but RVX's low side is 50%. 08 cents? It has reputable people on research boards. 2, find a partner that will want complete control (will DM go for that) and at best for us, 50% of the action, or 3, RVX is sold. )rvx announces type c meeting with fda for coral, a phase 3 high-risk covid-19 outpatient study posted on May 09, 2022 07:42AM Log in to use the IP Check tool [?]. Some other rumor or development leaking from the. At the highest level these companies have the same COB/CEO/President and the same VP of Accounting. Even having bets where the share price will end up once we get the results on BOM. The article and initiative provide good PR for repositioning the. We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY! Hub Navigation Hub Home ERA/EDTA Sunday, May 22, 2016. . Hepalink says they. NOTICE OF CHANGE OF AUDITOR TO: Alberta Securities Commission British Columbia Securities Commission Financial and Consumer Affairs Authority of Saskatchewan Manitoba Securities Commission Ontario Securities. $10. (RVX. A warrant at $4+. Where have I said "I believe both rvx & zen will be fine" this year? "just give me your understanding of what's going on without the nonsense please. Experimental and clinical - 1 [SP071] APABETALONE (RVX-208), A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, DECREASES ABUNDANCE AND ACTIVITY OF COMPLEMENT. Pfizer and Moderna seized the opportunity and seemingly shut the door on competitors. . Thanks Cottonmouth for your part in making this happen. Up until then, we were all flying high. Royalty on the sale of RVX-208 is 6% to 12% and Zenith Capital Corp could start receiving royalty revenue on sales of ZEN-3694 years before royalties from RVX-208 begin. But more importantly, if they were even willing to take a deal that low, please understand that they are totally signaling to a BP that we (RVX) think that what we are offering to you, based on all the. Since ZCC owns the RPS's and not the shareholders, below is an illustration of what it means and how that has been diluted. . Resverlogix and EVERSANA™ announce FDA Type C meeting for Phase 3 study CORAL in high-risk COVID-19. ). If Ken dart has not bailed it is safe to assume after a successful phase 3 trial rvx with ultimately be. Only the RVX. TO) stock quote, history, news and other vital information to help you with your stock trading and investing. Norman Wong is listed as having an August 30th poster presentation at 8:30 AM (London) in the poster session entitled: Lipids in atherosclerosis. Las Cristinas’ estimated 17 million ounces of gold positions Crystallex as one of the. We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY! Hub Navigation Hub HomeWelcome to the Crystallex HUB on AGORACOM Crystallex International Corporation is a Canadian-based gold company with a successful record of developing and operating gold mines in Venezuela and elsewhere in South America Hub Navigation Hub Home. My understanding is that many cancers are now treated as chronic conditions in which the patient moves through various treatments over time with no cure expected. but only if you want it! . . Dec 6, 2017 - RESVERLOGIX REPAYS $68. . News is frustratingly long in coming, but generally things still look good. Furthermore, ETC-1002 affects LDL class of lipoproteins and RVX-208 affects HDL class of lipoproteins (amongst several other cardioprotective pathways). I assume that the FDA would only accept data from their approved trials but it might get RVX doing some of these trials. Toinv, Buckeyes, RVXOldtimer, KK2 - Did we not hear at one point prior to the completion of BoM that there was a maximum number of patient that could be recruited in any one particular country? Memory is a little fuzzy but I think it was the AGM presentation the year prior to BoM wrapping up. Maybe i am being cynical, but i do believe the major insiders are happy to see RVX go bankrupt and take the IP with them. IMO They have been fooling DM all along. WRAPPED MINI SKIRT. Despite maybe being a day late Heh, to the extent that they can at this stock price Given the tendency of viruses to mutate, development of new strains, global extent of the problem, and long term impacts of this illness - apabetalone still has a potentially significant role to play. . , a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. by. As the writeup says there were 2 issues. I’ve been in the communications strategy business for over 30 years and my impression is that Chris is a skilled and sincere PR person. Message: Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latencyMessage: Re: What else can RVX treat that we don’t know about yet?"Check out RVX208 periodontal bone loss publication out of embargo. With total revenue of $2. . and Canada Myovant to receive an upfront payment of $650 million in addition to potential regulatory and sales milestones for a total. It appears Zenith may actually be a little further along these days with "active" and promising studies, partnerships, sale potential. (TSX: RVX) ("Resverlogix") today announced the publication of a peer-reviewed article, entitled "Apabetalone, a Clinical-stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human. I was even crazy enough to buy into the RVX. The bolding is mine. There was a comment that Israel and 1 or 2 other countries reached their maximum number of recruits. . Dec 12, 2017 - NATURE’S RECENT SCIENTIFIC REPORTS PUBLICATION DESCRIBES HOW APABETALONE MAY BE A POWERFUL. (the "Corporation") (TSX:RVX) today announced the acceptance for publication of a manuscript titled: "RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular. Enrollment was anticipated to begin June 1, 2016 and enrollment be. The cost of the CRPC drugs available today are somewhere between $100K and $150K per year. ZCC. 00%. 1 million to Zenith which represents the net present value of future payments to Zenith for Dividends on Royalty. ("Resverlogix" or the "Company") (TSX:RVX) announces that, further to its July 28, 2020 press release, it continues to rely on blanket exemptions issued by provincial securities. by. You flushed out a valuable bit of information from RVX regarding the upcoming AGM and pre AGM expectations. Over 700 Million Pages Of Small Cap Information Served To Over 8. Many just simply fell in love with RVX no. Back To Forum List ViewMessage: Re: According to the TMX website there are only 5 million RVX. Wow, a full warrant only 2 cents above subscription/market, and for FIVE years!!" "What happened to "Those selling shares on the market for $0. Its ridiculous that the BOD is excepting no. I fully expect this technology to show up in the future though, under one flag or another. S. fuzzyjr - What specific posts are you referring to, posted this year for me stating "exciting times ahead"', "defended this groups actions",. oristar and or any intersted BP. I think the basic idea of Zenith selling a royalty stream from Apabetalone as well as perhaps a Zenith drug would make sense depending on the splits (devil is always in the details). After the BOM miss, RVX made a strategic move to identify as a Covid therapy. Most likely due to poor management and lack of funds. Back To Forum List Viewquote from the news release: "I am excited to be part of this evolution in patient treatment as we advance the Cell Pouch cell therapy approach towards a functional cure for diabetes. 68%. So it seems. Is Covid (BoM2 recruiting) really slowing down a BP partner deal? Is Don/BoD hung up on a "big" number reach? Does RVX currently lack the internal business acumen, experience, and expertise to get it done? All valid questions,. Thank you. volume (for RVX) and a nice bump today. Back To Forum List ViewMessage: Re: A few thoughts on Soliris(Eculizumab) vs. Fouremm Your points are well taken and spot on. W. View real-time stock prices and stock quotes for a full financial overview. RVX Idea Mar 29 2023 Here’s a fun thought for Hump Day. 99. Maybe people are just leery of it. If this link doesn't work, search the registry for "Resverlogix" and you'll find it. Appears to get there, 1, very big stock sale, in the neighborhood of 500,000,000 shares to get $100 M. RVX is very close, no way to raise funds, paying employees with paper other than cash. . $. We provide novel science, clinical and value-based health solutions to key stakeholders such as pharmaceutical, physician, and health payer groups. We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY! Discussion Forum: Resverlogix Corp. Personally I hope it goes much higher than what you paid so the you and the rest of us make a bigger profit. Message: Re: Would a functional cure for T1D affect RVX and T2D?Message: Re: Nice early U. other than lining the pockets of Zenith share holders? chicagoest - good summary. I continually have to step back and look at the big picture to reenergize my committment - each time I do, I see the many positives in this company which made me a believer in this investment earlier. This Link Library has a treasure trove of information in it. WT = 5 mil +. . But more importantly, if they were even willing to take a deal that low, please understand that they are totally signaling to a BP that we (RVX) think that what we are offering to you, based on all the internal knowledge that we have over 20 years. This article suggests there is plenty of money out there to get the BoM2 job done. Here are the events leading up to the Resverlogix Annual General Meeting on September 30th. but only if you want it! Reply New Message Prev Message Back To Forum Threaded View Next Message. Back To Forum List View Resverlogix is a Canadian biotechnology company that develops apabetalone, a potential treatment for post COVID-19 conditions, chronic kidney disease,. 3 Million Investors. )narmac, management has been chasing its tail since we learned in 2019 that BOM did not meet its endpoint. S. The poster is. There are no individual shares of ZEL, only the ownership structure that has ZCC completely owning ZEL. " This adds to some other literature published/presented on RVX-2135 including this 2013 AACR meeting abstract and this 2014 PNAS paper2013 AACR meeting. 26 x 1500 June 16, 2022 1:24 PMEDTVolume: 65,800 CADTORONTO STOCK EXCHANGEDELAYED PRICEMessage: AMRN Chart very similar to RVX 7-8 months before their Phase ResultsSpecial Meetings for RVX and Zenith are 6/30 starting at 9AM Calgary timemessage: re: rvx announces type c meeting with fda for coral, a phase 3 high-risk covid-19 outpatient studyAs far as all these current trials go/zen what would be the next milestone/catalyst either starting or finishing of a certain trial(s) that would make zenith all the more attractive & viable for a real deal while at the same time would give Don & company the moneys or type of deal/comfort there looking for? What is the true. Financing is the dilemma. China’s data privacy laws deter researchers China’s new data restrictions have strengthened privacy but are concerning researchers globally. A while back I’d been researching the employee structures of Resverlogix vs. Find the latest Resverlogix Corp. . chicagoest - I'll give this a try, others may have to correct me. That would. I don't disagree with anything you have said. CEO Clips are run throughout the day, every day,. " When did we hear about RVX-208 and multiple sclerosis (MS)? A recent Resverlogix news release highlighted a potential for RVX-208 in Facioscapulohumeral. Message: Empowerment for the whining peasants, aka RVX retail. Calgary, Alberta--(Newsfile Corp. Speak with an Agoracom representative today. The market doesn't give a hoot what your buy-in price was or how big your loss is. $ 79. golfyeti. I think RVX has a good relationship with the EMA. My Warrant Eulogy. But it is. The first one are the RVX. )Message: Re: What else can RVX treat that we don’t know about yet?Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc. Zenith Epigenetics Corp was spun out of Resverlogix in May? of 2013 and has since changed its name to Zenith Capital Corp. Las Cristinas’ estimated 17 million ounces of gold positions Crystallex as one of the. CALGARY, July 21, 2016. . )Message: Re: Is this bad for RVX but right, on the money? Reply New Message. This PAV regression exceeded the trial's pre-specified PAV endpoint (-0. You indirectly own a proportionate value in those by. Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc. Personally I find it hard to believe that our big RVX investors are gonna take a deal as low as a $3. Go to that website above and scroll down a bit and you can get the pdf (or try clicking here ). fuzzy, I wouldn't count on ZCC for the following reasons; no trial is beyond phase 2 warrants, with one exception, are all dated 2028 Don is the CEO of ZCC. By the way, what is happening with the Hepalink deal. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic. It would be a game changer for RVX on all levels, BP would partner , would bring in new larger financing money. 2M.